Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Immunol. 2018 Aug 13;201(7):2094–2106. doi: 10.4049/jimmunol.1800578

Table I. Cytokine affinity and receptor exchange properties of engineered JES6–1 antibody and immunocytokine point mutants.

The JES6–1 antibody chains on which the mutations are located are indicated in parentheses.

Construct KD of IL-2/Antibody Complex (nM) KD of IL-2Rα/IC Complex (nM)
JES6–1 5.6 290
D55A (VH) 500 230
D58A (VH) 200 260
E60A (VH) 56 210
R62A (VH) 4.3 190
S34A (VL) 6.5 170
Y41A (VL) 6.4 130
H100A (VL) 62 240
Y101A (VL) 12 140